Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group.

Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9.

2.

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A.

Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Erratum in: Lancet. 2012 Aug 25;380(9843):730.

3.

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.

Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A, Correia M, Lyrer P, Kane I, Lundstrom E; IST-3 collaborative group.

Trials. 2011 Nov 30;12:252. doi: 10.1186/1745-6215-12-252.

4.

Pharmacy counselling models: a means to improve drug use.

Ax F, Brånstad JO, Westerlund T.

J Clin Pharm Ther. 2010 Aug;35(4):439-51. doi: 10.1111/j.1365-2710.2009.01138.x.

PMID:
20831546
5.

Electronically transmitted prescriptions not picked up at pharmacies in Sweden.

Ax F, Ekedahl A.

Res Social Adm Pharm. 2010 Mar;6(1):70-7. doi: 10.1016/j.sapharm.2009.06.003. Epub 2009 Oct 9.

PMID:
20188330
6.

Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability.

Winiwarter S, Ax F, Lennernäs H, Hallberg A, Pettersson C, Karlén A.

J Mol Graph Model. 2003 Jan;21(4):273-87.

PMID:
12479927
7.

Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.

Winiwarter S, Bonham NM, Ax F, Hallberg A, Lennernäs H, Karlén A.

J Med Chem. 1998 Dec 3;41(25):4939-49.

PMID:
9836611

Supplemental Content

Loading ...
Support Center